The Assessment of Clinical Usage and Prognostic Value of YKL-40 Serum Levels in Patients With Rectal Cancer Without Distant Metastasis.

Malgorzata FuksiewiczBeata KotowiczAndrzej RutkowskiJoanna Achinger-KaweckaMichal WagrodzkiMaria M Kowalska

Published in: Technology in cancer research & treatment (2018)

Pretreatment serum levels of YKL-40 may be a novel prognostic factor of overall and disease-free survival in patients with nonmetastatic colorectal cancer.

Keyphrases

free survival
prognostic factors
rectal cancer
locally advanced
lymph node
squamous cell carcinoma